Maker of starches and fructose looks for ways to alter portfolio amid scrutiny of ultra-processed foods
Researchers are trying to tackle the threat before nature’s ‘flying needles’ become more prevalent and resistant to prevention
Innovation prize targeting urinary tract infections boosts effort to tackle pathogens that develop immunity to drugs
Alcohol, food, tobacco and fossil fuel sectors oppose efforts to target conditions linked to 2.7mn deaths a year, warns WHO
A new WHO survey suggests that they are more exposed than men to superbugs
Health authorities move to protect farmworkers and other high-risk groups after recent outbreaks
Vaccine maker to seek approval for jab as it tries to diversify product pipeline
Launch highlights growth of venture philanthropy to boost search for treatments and cures
As incidence rises, breakthroughs in oncology show the value of research funding
‘Gene desert’ research boosts knowledge of chronic disease mechanisms and promises to unlock novel therapies
Radical advances in neurotechnology are helping disabled people walk and could provide the link between human and artificial intelligence
Experts warn that epidemics of the mosquito-born virus will become more common as a result of climate change
US decision hands biotech group its first regulatory blessing since its blockbuster Covid-19 jab
The writer and campaigner on love, last wishes and the divisive debate over assisted dying
Funding would help to bolster stockpile as CDC reports third dairy worker infected
US group hopes EyeBio will refill its pipeline with treatments targeting causes of blindness
US drugmaker races to scale up ingredient production to meet demand for Mounjaro and Zepbound jabs
As Covid revenues slump, technology developed to fight the pandemic is having some success combating this disease
Anopheles stephensi modified so that the biting females would die
Fears of growing outbreak drive revival in vaccine group stocks which have been out of favour since pandemic ended
An FT special report looking at changes in healthcare, treatments and illness itself
Serum Institute of India says it is losing money on each dose it supplies for historic first mass vaccination campaign
Brian Langstaff’s long-awaited report found failures by government departments and various parts of NHS
Clinical study shows better hand and arm function after using non-invasive device to stimulate spinal cord
So-called FLiRT strains set to test effectiveness of vaccines against latest mutations
UK Edition
